Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of unknown etiology characterized by progressive loss of motor neurons (MNs). Most ALS cases are sporadic and ~10% are familial, yet the two classes are clinically indistinguishable suggesting that similar pathways may be responsible for the MN degeneration. Defects in nucleocytoplasmic transport (NCT) have been observed in both cellular and in vivo models of ALS and reinforced by pathological evidence in familial and sporadic ALS patients [1] [2] [3] [4] [5] [6] . Nuclear deficiency of mRNAbinding proteins (RBPs) such as TDP-43 and FUS is a pathological hallmark of the disease 7 , strongly supporting a link between NCT and ALS pathogenesis.
NCT is a tightly regulated process that actively controls the separation between cytoplasmic and nucleoplasmic proteins and RNAs. It is centered on the function of the nuclear pore complex (NPC), a multiprotein complex spanning the whole nuclear envelope and comprised of about 30 different nucleoporins 8 . Other key players controlling NCT are the small GTPase Ran, its GTPase-activating protein RanGAP1, and the carrier proteins importins and exportins. The cellular distribution of these factors confers directionality to the transport 9 , while the structural integrity of the NPC and their density across the nuclear envelope modulate the efficiency of the NCT. Interestingly, nucleoporins are the longest lived proteins in the cell, and they are not replaced once the NPC is formed in postmitotic neurons 10, 11 .
Toxic insults such as oxidative stress and protein aggregation have been shown to negatively impact NCT 12, 13 . Many mutant ALS-linked proteins show an increased tendency to aggregate, including SOD1, TDP-43, FUS, and Profilin1 (PFN1). PFN1 is a small actin-binding protein that positively regulates actin polymerization in a formin-dependent manner. ALS-linked mutations in PFN1 render the protein unstable and aggregation prone, leading to the formation of cytoplasmic inclusions 14, 15 . The ability of mutant PFN1 to associate with filamentous (F)-actin is also impaired, and mutant PFN1 MNs show morphological abnormalities, such as smaller growth cones and shorter axons 15 . However, the molecular mechanisms leading to MN degeneration due to mutations in PFN1 are still unknown. Here we demonstrate that alterations to the actin cytoskeleton caused by mutant PFN1 disrupt the NCT and consequently the normal function of ALS-relevant RBPs, leading to MN dysfunction. Interestingly, modulating actin homeostasis was able to rescue the NCT defects caused by not only mutant PFN1 but also C9ORF72 repeat expansion, suggesting this could represent a novel therapeutic strategy for ALS.
RESULTS

Mutations in PFN1 impair nucleocytoplasmic transport
To investigate whether mutant PFN1 toxicity is associated with nucleocytoplasmic transport (NCT) defects, we examined its effects on the distribution of essential factors controlling this process. To visualize the localization and composition of the nuclear pore complex (NPC) along the nuclear envelope (NE), we stained primary motor neurons (MNs) expressing WT or mutant PFN1 (C71G and G118V) with antibodies recognizing nucleoporins of the FG-Nup family, Nup358/RanBP2, and the transmembrane Nup POM121, given their essential role in regulating NPC structure and function [16] [17] [18] . In WT cells a strong, punctate staining was observed around the nucleus similar to untransfected controls, while a significantly higher percentage of mutant PFN1 MNs showed reduced or absent staining at the NE ( Figure   1A -B, S1-S2). Consistent with its known association to the NPC via RanBP2, RanGAP1 localized along the NE in WT cells, while its staining pattern was partially or completely disrupted in mutant PFN1 MNs ( Figure 1C ). The presence of mutant PFN1 led the transport factor Ran to be abnormally redistributed to the cytoplasm, in contrast to its mostly nuclear localization in WT cells ( Figure 1D ). This effect was more pronounced in cells containing visible inclusions, although MNs with no obvious aggregates still had Ran C:N ratios significantly higher than WT values. No co-aggregation of any of the tested proteins with mutant PFN1 was observed ( Figure 1E -G), and no changes in RanGAP1 SUMOylation, which is necessary for its association with the NPC 19 , were detected ( Figure 1H ). Similarly, no difference in the overall levels of the tested nucleoporins was observed in all conditions, while a slight reduction in Ran levels was present in PFN1 C71G MNs ( Figure S3 ). We did not observe changes to the localization of karyopherins, with the exception of a small reduction in Exportin 1 (XPO1) levels ( Figure S4 ). , and RanGAP1 (C, green) localization to the NE is altered in a higher percentage of MNs expressing V5-tagged mutant PFN1 vs WT control (red). D. Ran (green) cytoplasm to nucleus (C:N) ratio is increased in MNs expressing V5-WT or mutant PFN1 (red), regardless of the presence of aggregates (agg), indicating possible functional defects in the segregation of cytoplasmic and nuclear proteins. E. The presence of PFN1 C71G aggregates (red) in MNs does not lead to co-aggregation of FG-Nups, POM121, RanGAP1, or Ran (green). F. No difference in the solubility of Ran (middle panel) or RanGAP1 (top panel) caused by the expression of PFN1 mutants when assayed in HEK293 cells using detergent-based cellular fractionation. Triton X-100 (2%) and urea (8M) were used to extract the soluble and insoluble fraction, respectively. G. Representative blot of a co-immunoprecipitation (co-IP) assay between V5-tagged WT or mutant PFN1 and RanGAP1 (top panel) or Ran (middle panel). No bands were detected in the IP pellet, suggesting lack of interaction. H. Representative western blot and quantification showing unchanged levels of SUMO1-modified RanGAP1 in the presence of mutant PFN1. Both antibodies against SUMO1 (top panel) and RanGAP1 (second panel) detect a band ~80KDa corresponding to SUMOylated RanGAP1. V5 antibody (bottom panel) shows the expression of the V5-tagged PFN1 protein, while β-tubulin was used as a loading control. Bars are mean±SEM; *p<0.05, **p<0.01, ***p<0.001. DAPI (blue) was used to detect the nucleus and assess cell health. Scale bars: 10µm. See also Figure S1 -S4, and Table S1 for details on statistics.
Mutant PFN1 alters the structure of the nuclear membrane
Since the NPC is tightly connected with the nucleoskeleton, we further investigated the effect of mutant PFN1 on the nuclear structure using transmitted electron microscopy. Similarly to what was observed in cells expressing TDP-43 C-terminal fragment 1 , we found that the expression of either V5-tagged or GFP-tagged PFN1 C71G in Neuro2a cells led to severe defects in the structure of the nucleus, with the presence of frequent folds, invaginations, and protrusions that were never observed in untransfected or PFN1
WT -transfected cells (Figure 2A ). Figure  S1 and S3, and Table S1 for details on statistics.
Nuclear import is greatly reduced by mutant PFN1
To further explore the functional consequences of the structural defects caused by mutant PFN1 on the NCT, we measured the rate of nuclear import by live cell imaging using a NLS-NES-mCherry (Shuttling (S)-mCherry) reporter 20 . Cortical neurons were co-transfected with GFP or GFP-tagged PFN1 and S-mCherry. S-mCherry localized mainly to the cytoplasm in all conditions due to the stronger effect of the nuclear export signal (NES) compared to the nuclear localization signal (NLS)( Figure 3E ).Thirty-six hours after transfection, cells were treated with Leptomycin B (LMB) -a selective inhibitor of Exportin 1 -to inhibit nuclear export, leading to a measurable time-dependent accumulation of the reporter in the nucleus. We found that the expression of mutant PFN1 led to a significant reduction in import rates compared to both GFPand PFN1
WT -transfected cells ( Figure 3A-C) , and an increase in the percentage of nonresponder cells (39% in C71G vs 6% WT) ( Figure 3D ). In all, these data suggest that mutant PFN1 may affect nuclear stability, altering either the composition and/or the number of functional NPCs, and thus leading to severe nuclear import defects. Regression analysis of S-mCherry kinetics (C) and percentage of cells whose nuclear levels did not rise above 1.2 folds over initial values upon the application of LMB (i.e. non-responders, D). E. SmCherry (red) C:N ratio is not affected by mutant PFN1 (green) in untreated cells. GFP alone was used as control, and localizes to both nucleus and cytoplasm. Bars are mean±SEM; *p<0.05, **p<0.01, ***p<0.001. DAPI (blue) was used to detect the nucleus and assess cell health. Scale bars: 10µm. See Table S1 for details on statistics.
mRNA post-transcriptional regulation is impaired in mutant PFN1 cells
One of the main classes of proteins that shuttle between the nucleus and the cytoplasm are RBPs which control the post-transcriptional fate of mRNAs. Thus, we investigated the impact of mutant PFN1-dependent disturbance to NCT on the distribution of RBPs by quantifying the nuclear and cytoplasmic levels of the mostly nuclear proteins TDP-43 and FUS, and of the mostly cytoplasmic proteins SMN and FMRP. As expected, the majority of TDP-43
and FUS was nuclear in WT-expressing MNs, while mutant PFN1 expression led to a shift in the C:N ratio of both proteins ( Figure 4A -B). Again, no effect of PFN1
WT expression was observed on the localization of the proteins compared to untransfected controls ( Figure S5 ). On the contrary, there we no quantifiable changes to the distribution of the mostly cytoplasmic FMRP and SMN proteins, although we observed fewer SMN-positive nuclear gems ( Figure S6 ). We also observed a significant reduction in TDP-43 localization to the proximal motor axon ( Figure   S5 ) and an increase in TDP-43 aggregation, possibly mediated by TDP-43's illegitimate interaction with mutant PFN1 ( Figure S7 ). Together, these data suggest that mutant PFN1
perturbs the distribution of ALS-relevant nuclear RBPs by destabilizing the NPC and impairing nuclear import. To investigate the downstream consequences of PFN1-mediated mislocalization of such RBPs, we focused as a proof of principle on TDP-43's well-studied regulatory activity on the axonal localization of the neurofilament L (Nefl) mRNA 21 and on the splicing of POLDIP3 Representative DNA gel and quantification of the levels of the POLDIP3 S2 variant over total POLDIP3 levels (S1+S2) in control (Ctrl) versus mutant PFN1 lymphoblast lines. Bars are mean±SEM; *p<0.05, **p<0.01, ***p<0.001. DAPI (blue) was used to detect the nucleus and assess cell health. Scale bars: 10µm. See also Figure S5 -S8, and Table S1 for details on statistics.
Inhibition of nuclear export improves ALS relevant disease phenotypes
To assess the causality between NCT disturbance, RBP mislocalization, and MN pathology, we investigated the potential of nuclear export inhibitor KPT-276, a well-established selective inhibitor of XPO1 6, 23, 24 , to rescue PFN1-dependent defects. First, WT or C71G expressing MNs were treated with 50nM KPT-276 or DMSO 6 hours prior to fixation, and the C:N ratio of TDP-43 was determined. KPT-276 treatment was able to fully rescue TDP-43 cytoplasmic mislocalization ( Figure 5A ), confirming successful inhibition of nuclear export. Next, we sought to determine the potential of KPT-276 treatment to rescue axonal outgrowth defects previously described in mutant PFN1 MNs 15 . MNs expressing mutant PFN1 and treated with Representative time lapse images and quantification of axon outgrowth in the presence or absence of KPT-276. A full rescue of the outgrowth defects was observed following KPT-276 treatment. Bars are mean±SEM; *p<0.05, ***p<0.001. DAPI (blue) was used to detect the nucleus and assess cell health. DMSO was used as vehicle control. Scale bars: 10µm. See also Table S1 for details on statistics.
vehicle alone had significantly shorter axons than WT cells, while KPT-276 treatment fully rescued the defect ( Figure 5B ). Similar rescue was observed by measuring the rate of axon growth by live cell imaging over the course of 1 hour ( Figure 5C , Movie S1). Together, these data support a direct link between NCT, mRNA regulation, and PFN1-dependent ALS pathology.
Modulation of actin polymerization modifies NCT in mutant PFN1 MNs
PFN1's main cellular function is to promote actin polymerization by facilitating forminbased actin nucleation and elongation, a function impaired by the presence of ALS-linked mutations 14, 15 . Thus, we hypothesized that PFN1-mediated disruption of the actin network could directly interfere with protein nuclear shuttling by affecting nuclear stability. Overexpression of a constitutively active form of the formin mDia1 (FH1-FH2 domains) in mutant PFN1 MNs was indeed able to restore normal actin homeostasis ( Figure S9 ), without changing the aggregation propensity of PFN1 C71G . Importantly, while mutant PFN1 MNs expressing GFP alone had significantly higher frequency of disrupted RanGAP1 staining, as previously observed (see Figure 1 ), the expression of GFP-mDia1 fully rescued the defect ( Figure 6C ). Similarly, GFP-mDia1 expression was able to rescue TDP-43 mislocalization ( Figure 6D ) in mutant PFN1 MNs. To assess whether actin modulation could also rescue the function of the nuclear pore, we again measured import dynamics of S-mCherry in the presence of mDia1 overexpression. A significant improvement of import dynamics was observed in PFN1 C71G neurons following mDia1 expression ( Figure 6E-H) , suggesting that changes in actin homeostasis can influence the stability of the NPC and/or NE, affecting protein shuttling. . E-F. Time-lapse images and quantification of S-mCherry import dynamics upon treatment with LMB in cortical neurons expressing GFP or GFP-mDia1 (green) and V5-tagged PFN1 (white). S-mCherry levels are shown as 16-bit heat map. Dashed lines indicate the nucleus. Cells were post-fixed and stained to verify expression of V5-PFN1 constructs (white). G-H. Regression analysis of S-mCherry kinetics (G) and percentage of non-responder cells (H). Bars are mean±SEM. *p<0.05, **p<0.01, ***p<0.001. DAPI (blue) was used to detect the nucleus and assess cell health. Scale bars: 10µm. See also Figure S9 and Table S1 for details on statistics. . As anticipated, expression of (G4C2)80 repeats in MNs led to the loss of RanGAP1 localization to the NE with no change to its overall levels ( Figure 7A and S10) 6 . Interestingly, overexpression of the constitutively active form of mDia1 fully rescued the phenotype. Notably, mDia1 expression was also able to rescue functional import defects as detected by SmCherry dynamics (Figure 7B-D) . Together, these results suggest that modulation of actin homeostasis directly modifies the stability of the NPC and/or NE, protecting it from disruption caused by ALSassociated gene mutations.
Modulation
DISCUSSION
ALS is a heterogeneous disease and mutations in a wide array of genes are associated with ALS pathogenesis 28 . Although a common mechanism linking these different gene mutations may not be immediately apparent, recent findings from several groups point at defects in NCT as central to ALS pathology 29 . Here we explore the hypothesis that alterations in cytoskeletal stability caused by ALS-associated mutations in the actin-binding protein PFN1
would similarly impact the function of the NPC.
Our immunofluorescence data in primary MNs show that mutant PFN1 leads to a severe impairment of the NPC structure and/or number, marked by the loss of nucleoporins from the nuclear envelope, as well as of its function, as indicated by the dissolution of the nucleocytoplasmic gradient of Ran, reduced import rates, and cytosolic mislocalization of nuclear RBPs TDP-43 and FUS. No changes in the distribution of cytoplasmic shuttling proteins (i.e. SMN, FMRP, S-mCherry, and PFN1 itself) were detected, suggesting that mutant PFN1 mostly affected nuclear import versus export. To investigate how mutant PFN1 disrupts the NCT, we tested whether it directly affected RanGAP1 protein levels or its association with the nuclear pore, as suggested in flies where loss of function of PFN1 ortholog Chic was associated Figure S10 and Table S1 for details on statistics.
with selective RanGAP1 irregular localization to the NE 30 . However, we did not detect any change in RanGAP1 levels or SUMOylation, which is necessary for its binding to the NPC. Next, we investigated whether PFN1 aggregation could sequester NCT factors, thus causing impairment in nuclear shuttling as shown for synthetic amyloid aggregates and TDP-43 1, 12 . Again, we were not able to detect increased insolubility or co-aggregation of the factors tested with PFN1 inclusions. Additionally, while TDP-43 aggregates are cross-seeded by PFN1 15, 31 , we observed mislocalization of nucleoporins and Ran even in the absence of PFN1 inclusions, suggesting that TDP-43 mislocalization is a consequence rather than the cause of NCT disturbance. Finally, we excluded from our analyses any of the rare cells with spontaneous stress granule-like formation due to PFN1 overexpression 32 , thus eliminating the possibility that stress granules would induce NCT defects in our experimental system 13 . A more likely scenario is that mutant PFN1-dependent disruption of the actin cytoskeleton destabilizes the nuclear membrane, leading to NCT defects. This is supported by the observation that actin depolymerization caused by Latrunculin A was sufficient to cause severe changes in the cellular distribution of Ran and RanGAP1, and that the overexpression of the constitutively active form of mDia1, by promoting filamentous actin polymerization and without changing PFN1 aggregation propensity, was able to structurally and functionally rescue the NPC. Intriguingly, we found that mDia1 rescue was not limited to mutant PFN1 cells, but extended to cells expressing the C9ORF72 repeat expansion, the most common mutation found in ALS patients.
Although the mechanisms driving this rescue are not fully understood yet, we speculate that actin may act by modulating the integrity of the NE via the function of the linker of nucleoskeleton and cytoskeleton (LINC) complex 33 , a multiprotein complex that physically connects lamins with actin and microtubules. Of note, mutations in LINC components cause cerebellar ataxia 34, 35 , suggesting that this complex plays an important role in the maintenance of neuronal function and survival, possibly through the modulation of NPC function. Future work will be required to reveal how changes to actin homeostasis affect the LINC complex and its functional consequences on the NCT and how subtle changes to actin polymerization could be employed as a strategy to modulate NCT function.
It remains an open question whether the NCT defects observed in our model and others are a cause or a mere effect of the degenerative process. Our data strongly argue for the NPC dysfunction being a primary driving force of ALS-associated cell toxicity. Indeed, we found that pharmacological inhibition of nuclear export rescued PFN1-dependent cellular pathology, such as stunted axon growth. Together with previous observation connecting deficiencies in NCT to axonal guidance defects in flies 36 , our data are particularly interesting as they functionally link the cytoskeleton with NCT and mRNA post-transcriptional regulation. Axon growth is a complex process that requires active cytoskeletal growth 37 , fueled by the increased expression, transport, and local translation of several cytoskeletal-related mRNAs 38, 39 . Defects in the localization and local translation of mRNAs at the tip of axons and dendrites has been described in other neurological diseases, such as SMA and Fragile X syndrome 40, 41 , supporting the relevance of these defects in disease pathogenesis. Our data suggest that PFN1-dependent impairment of NCT and consequent mislocalization/loss of function of nuclear RBPs leads to impaired mRNA regulation, of which POLDIP3 mRNA splicing and Nefl mRNA axonal localization are two examples. Together, these data support our hypothesis that PFN1-mediated and actin-dependent disruption of NCT may have severe downstream consequences on general mRNA regulation, leading to a vicious cycle that eventually leads to MN degeneration. Rescue in either of these pathways would positively impact the others possibly preserving MNs in ALS.
In conclusion, our results suggest a model whereby modulations to actin dynamics can affect the stability and function of the nuclear pore, adding cytoskeletal function to the list of modulators of NCT, together with protein aggregation and oxidative stress 1, 13 . The defects in NCT observed in ALS MNs could be particularly relevant to disease pathogenesis as it may compromise many cellular pathways relying on the integration between signaling and changes in gene expression and/or mRNA processing, such as neurotrophic factors signaling or oxidative stress [42] [43] [44] . Failure to integrate these signaling cascades would decrease the cell's ability to respond to environmental challenges, leading to the accumulation of toxic insults.
Regulating nuclear export or restoring NPC function via modulation of actin could represent feasible therapeutic strategies for multiple forms of ALS and other neurodegenerative diseases beyond ALS.
MATERIAL and METHODS
Primary motor neuron culture, transfection, and treatments.
Primary motor neurons (MNs) were isolated from E12.5 mouse embryonic spinal cords dissociated in 0.1% trypsin (Worthington) at 37C for 12 minutes. MNs were purified using a 6%
Optiprep (Sigma-Aldrich) density gradient and plated on glass coverslips coated with 0.5g/L poly-ornithine (Sigma-Aldrich) and laminin (Thermo Fisher). Cells were grown at 37C and 5% CO2 in Neurobasal medium (Thermo Fisher) supplemented with 0.25% Glutamax, 2% B27, 2% horse serum, and 10ng/ml BDNF, GDNF, and CNTF. MNs at 2 days in vitro (DIV) were transfected using 1.75µl NeuroMag reagent (OZ Biosciences) + 0.5µg DNA. Complete growth medium was replaced with serum free neurobasal medium 1 hour prior and after transfection.
The V5-PFN1 plasmids were described in Wu et al. (2011) , while the (G4C2)80 construct was described in 26 . For the GFP-PFN1 constructs, WT or mutant PFN1 was PCR amplified from the V5 constructs and cloned in the pEGFP-C1 backbone using BamHI sites. The FH1-FH2 domains of murine mDia1 (aa 553-1192) were PCR amplified using specific primers and cloned into the pEGFP-C1 plasmid using XhoI and BamHI restriction sites. GFP or GFP-mDia1 were co-transfected in a 1:2 ratio with PFN1 or C9ORF72 plasmids. For actin depolymerization assays, 2DIV MNs were treated with 0.1mg/L Latrunculin A (Cayman) for 3 days. For nuclear export inhibition, MNs were treated with 50nM KPT-276 (Selleck) or equal volume of DMSO (Sigma Aldrich) 1 day after transfection.
Primary cortical neuron culture, transfection, and treatments
Primary cortical neurons were isolated from E15 mouse embryos dissociated in 0.05% trypsin-EDTA (Thermo Scientific) at 37C for 12 minutes. 320,000 cells/ml were plated on poly-D-lysine (0.125 mg/ml, Sigma Aldrich) and lamin (5 µg/ml, Corning) coated 96-well glass plates and grown at 37C and 5% CO2 in Neurobasal medium (Thermo Fisher) supplemented with 2% B27 and 1% Glutamax (Thermo Scientific). Four DIV neurons were transfected with 0.2µl
Lipofectamine 2000 (Thermo Scientific) and 100ng DNA following manufacturer's recommendations. A ratio of 4:1 was used for the GFP and S-mCherry vectors. Thirsty-six hours after transfection, Leptomycin B (10mg/L) was added to the culture medium immediately before image acquisition. Cells were imaged using a Nikon TiE widefield microscope equipped with temperature-and CO2-controlled environmental chamber. Movies were acquired with a 20x lens at a rate of 1 frame every 1 or 2 minutes for 1 hour. For rescue experiments, neurons were fixed immediately after acquisition and stained with V5 antibody to detect V5-PFN1 expression.
Immunofluorescence and image acquisition
Cells were fixed with 4% paraformaldehyde for 15 minutes. Fixed motor neurons were treated with hot 10mM citrate buffer, pH 6 for 20 minutes before permeabilization with 0.2% Triton-X 100 for 5 minutes. Cells were blocked with 5% bovine serum albumin for 45 minutes and hybridized with the appropriate antibodies overnight at 4C. Anti-mouse and anti-rabbit donkey secondary antibodies or phalloidin conjugated with either Alexa Fluor 647, Alexa Fluor 594, Alexa Fluor 546, or Alexa Fluor 488 (Jackson Immunoresearch and Thermo Fisher) were hybridized for 1 hour at room temperature. Coverslips were mounted onto a glass slide using Prolong Gold mounting medium (Thermo Fisher) and imaged using an epifluorescence microscope (Nikon Ti E) equipped with a cooled CMOS camera (Andor Zyla). Images were acquired as Z-stacks (0.2µm step size) using a 60x lens unless otherwise specified.
Transmission Electron Microscopy
Six-well plates of cultured cells were fixed overnight at 4°C by adding 1 ml of 2.5% 
Fluorescence in situ hybridization
Motor neurons were fixed in 4% RNase-free paraformaldehyde for 15 minutes, and stored in 70% ethanol at 4C overnight. Cells were sequentially incubated for 5 minutes in 1x PBS and wash buffer (2x SSC, 10% formamide), and hybridized in hybridization buffer (10mg/ml dextran sulfate, 4mg/ml BSA, 40µM ribonucleoside vanadyl complexes, 2x SSC, 1% PBS) at 37°C overnight with 12.5µM probes and 0.2mg/ml each salmon sperm DNA and E. Coli tRNA.
Neurofilament L mRNA specific probes were design using Biosearch Technology online tool and conjugated with the Quasar® 570 fluorophore (Table S2) . Coverslips were then washed twice for 30 minutes at 37°C in wash buffer before mounting them as described above.
Axon length and outgrowth analysis
Motor neurons were co-transfected as outlined above with green fluorescent protein (GFP) and V5-tagged PFN1 constructs in a 1:2 ratio. KPT-276 (50nM) or equal volumes of DMSO were added to the culture medium 1 day after transfection and maintained throughout the experiment for a total of 3 days. Cells were fixed and stained to detect V5-PFN1 expression 4 days after transfection. Cells were imaged as individual focal planes using a 10x lens. GFP was used to identify transfected cells and highlight the whole cell structure. For live imaging of axon outgrowth, KPT-276 (50nM) or equal volumes of DMSO were added to the culture medium 1 day after transfection and maintained throughout the experiment for a total of ~18-24 hours.
Cells were imaged at 3 DIV using a Nikon TiE widefield microscope equipped with temperatureand CO2-controlled environmental chamber. Movies were acquired with a 20x lens at a rate of 1 frame every 10 minutes for 1 hour.
Immunoprecipitations, solubility assays, and western blots HEK293 cells grown in DMEM + 10% FBS were transfected with V5-PFN1 constructs and lysed with lysis buffer (20mM Tris, 150 mM NaCl, 1% Triton X-100, protease inhibitor Complete EDTA-free, Roche) 24 or 48 hours after transfection. For immunoprecipitations, the detergentsoluble lysates were added to 30 µL of Protein A-Agarose beads (Roche) and 0.3 µg of anti-V5 antibody (Novus) and rocked overnight at 4°C. Immunoprecipitated complexes were eluted in Laemmli buffer (60mM Tris-Cl pH 6.8, 2% SDS, 10% glycerol, 5% beta-mercaptoethanol, 0.01% bromophenol blue) and then subjected to western blot analysis. For solubility assays, lysates were sonicated on ice and then centrifuged at 16,000 x g for 10 min at 4°C. The supernatant was collected as the soluble fraction. The pellet was washed three times with lysis buffer, resuspended in 8M urea, sonicated, and then centrifuged at 16,000 x g for 10 min at 4°C. The supernatant was collected as the insoluble fraction.
Samples were resolved by SDS-PAGE on Mini Protean TGX 4-20% gradient polyacrylamide gels (Bio-Rad) and transferred onto nitrocellulose membranes (Bio-Rad). Membranes were blocked with Odyssey Blocking Buffer (LI-COR) and probed with primary antibodies overnight.
Secondary antibodies conjugated with IRDye ® infrared fluorophores (LI-COR) were incubated for 1 hour at room temperature. Blots were visualized using the Odyssey Infrared Imaging System (LI-COR).
POLDIP3 splicing assay
Immortalized lymphoblastoid cell lines obtained from 3 ALS patients carrying PFN1 mutations and 4 controls 15 were cultured in RPMI medium supplemented with 15% fetal bovine serum (FBS). Whole RNA was extracted from 5x10 6 cells using TriZol reagent (Thermo Fisher) according to manufacturer's instructions. RNA (2µg) was retrotranscribed using the HighCapacity cDNA Reverse Transcription Kit (Thermo Fisher). RT-PCR was performed using specific primers amplifying exon2-exon4 of human POLDIP3 mRNA. DNA gels were stained with SYBR Safe dye (Thermo Fisher) and imaged using the ChemiDoc XR+ imager (BioRad).
Image processing and quantification
Immunofluorescence images were deconvolved using an adaptative blind deconvolution algorithm (Autoquant X3, Media Cybernetics) before analysis. To measure fluorescence intensities, the signals were thresholded and the resulting integrated densities were normalized on the area of the selected region (e.g. cell body, nucleus). Thresholds were kept consistent for all images within experiments. For all experiments, values were normalized to WT averages so that WT always = 1±SEM. For NCT dynamics, the fluorescence intensity of S-mCherry was measured in the nucleus using ImageJ and normalized to the background for every time point.
All values were subsequently normalized to T0. For the analysis of axonal fluorescence intensities, a 100µm long region of the proximal axon was measured in all conditions. Axon lengths were measured using the ImageJ plugin NeuronJ 45 . The axon was defined as the longest neurite. The rate of axon outgrowth was measured using the ImageJ plugin MTrackJ by tracking the movement of the growth cone in all fields 46, 47 . A blinded analysis was performed to assess RanGAP1, RanBP2, POM121, and F-Nups localization. For all experiments, raw values were normalized to the mean of the control condition.
Statistical Analysis
Statistical analyses were performed using Prism 7 software package (GraphPad). Normality of the samples was assessed using the D'Agostino & Pearson Omnibus test. According to normality, parametric or non-parametric tests were used to assess significance, defined as p<0.05. Detailed information on all statistical tests performed is listed in Table S1 .
Data Availability
The datasets generated during the current study are available from the corresponding author on reasonable request.
